19 October 2016

Walgreens Boots Alliance Honored with United Nations Foundation Global Leadership Award

NEW YORK,  October 19, 2016 - The United Nations Foundation’s 2016 Global Leadership Awards Dinner will tonight honor Walgreens Boots Alliance, Inc. (Nasdaq: WBA) for its commitment to the UN’s Sustainable Development Goals through its support for wellbeing around the world. The award recognizes, in part, the accomplishments of Walgreens highly successful Get a Shot. Give a Shot.® initiative, which provides life-saving vaccines to children in developing countries through the Foundation’s Shot@Life campaign. Walgreens Boots Alliance’s Co-Chief Operating Officer Ornella Barra will accept the Global Leadership Award on behalf of the company.

12 October 2016

Walgreens Boots Alliance Declares Regular Quarterly Dividend

DEERFIELD, Ill. 12 October 2016 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 37.5 cents per share, an increase of 4.2 percent over the year-ago period. The dividend is payable 12 December 2016 to stockholders of record as of 17 November 2016.

14 September 2016

Walgreens Boots Alliance Schedules Fiscal 2016 and Fourth Quarter Earnings Announcement for 20 October 2016

DEERFIELD, Ill., 14 September 2016 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2016 and fourth quarter earnings results at 7 a.m. Eastern time Thursday, 20 October 2016, followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

08 September 2016

Walgreens Boots Alliance Provides Update on its Pending Acquisition of Rite Aid

DEERFIELD, Ill., 8 September 2016 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today provided the following update on its pending acquisition of Rite Aid Corporation (NYSE: RAD).
 

25 August 2016

Walgreens Boots Alliance Exercises Second Tranche of Warrants to Purchase AmerisourceBergen Shares

DEERFIELD, Ill., 25 August 2016 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it had agreed with AmerisourceBergen Corporation (NYSE: ABC) to amend the second tranche of warrants held by Walgreens Boots Alliance to purchase AmerisourceBergen common stock, so as to permit the immediate exercise of these warrants. The warrants were originally scheduled to be exercisable in March 2017.

26 July 2016

Walgreens Boots Alliance Announces Secondary Common Stock Offering

DEERFIELD, Ill., July 26, 2016 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “company”) today announced that affiliates of Kohlberg Kravis Roberts & Co. L.P. (“KKR,” and together, the “selling stockholders”) intend to offer for sale in an underwritten secondary offering 15,000,000 shares of the company’s common stock pursuant to the shelf registration statement (File No. 333-209569) filed by the company with the Securities and Exchange Commission (the “SEC”) on 17 February 2016.

18 July 2016

Boots to launch in South Korea

DEERFIELD, Ill., 18 July 2016 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise, today announced that it has signed an agreement to form a franchise partnership with Emart Company Ltd (a member of Shinsegae Group), South Korea’s number one hypermarket retailer. Together, they will create a Boots branded pharmacy-led, health and beauty retail franchise in South Korea. 

13 July 2016

Walgreens Boots Alliance Increases Quarterly Dividend

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 37.5 cents per share, an increase of 4.2 percent.

07 July 2016

Walgreens to Participate in U.S. Precision Medicine Initiative Cohort Program through The Scripps Research Institute

DEERFIELD, Ill., 7 July 2016 – Walgreens, one of the largest drugstore chains in the USA and included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), will participate in the USA Precision Medicine Initiative (PMI) Cohort Program through an initial $20 million grant awarded to The Scripps Research Institute (TSRI) by the National Institutes of Health (NIH).

06 July 2016

Walgreens Boots Alliance Reports Fiscal 2016 Third Quarter Results

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter and first nine months of fiscal year 2016 that ended 31 May 2016.

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.